Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|August 30, 2008
Mutations M184V and Y115F in HIV-1 reverse transcriptase discriminate against "nucleotide-competing reverse transcriptase inhibitors"Maryam Ehteshami, Brian J Scarth, Egor P Tchesnokov, et al.
Infection and Drug Resistance|March 14, 2014
Approaches to hepatitis C treatment and cure using NS5A inhibitorsJames J Kohler, James H Nettles, Franck Amblard, et al.
The Journal of Biological Chemistry|July 9, 2011
Impact of primer-induced conformational dynamics of HIV-1 reverse transcriptase on polymerase translocation and inhibitionAnick Auger, Greg L Beilhartz, Siqi Zhu, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2017
Characterization of β-d-N4-Hydroxycytidine as a Novel Inhibitor of Chikungunya VirusMaryam Ehteshami, Sijia Tao, Keivan Zandi, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 10, 2019
Intracellular metabolism and potential cardiotoxicity of a β-D-2'-C-methyl-2,6-diaminopurine ribonucleoside phosphoramidate that inhibits hepatitis C virus replicationSijia Tao, Longhu Zhou, Hongwang Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2016
Discovery, characterization, and lead optimization of 7-azaindole non-nucleoside HIV-1 reverse transcriptase inhibitorsRichard A Stanton, Xiao Lu, Mervi Detorio, et al.
ACS Medicinal Chemistry Letters|January 29, 2016
Synthesis and Evaluation of 2,6-Modified Purine 2'-C-Methyl Ribonucleosides as Inhibitors of HCV ReplicationLonghu Zhou, Hongwang Zhang, Sijia Tao, et al.
The Journal of Infectious Diseases|February 23, 2010
Epidemiological and biological evidence for a compensatory effect of connection domain mutation N348I on M184V in HIV-1 reverse transcriptaseViktor von Wyl, Maryam Ehteshami, Jori Symons, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2010
HIV-1 reverse transcriptase connection domain mutations: dynamics of emergence and implications for success of combination antiretroviral therapyViktor von Wyl, Maryam Ehteshami, Lisa M Demeter, et al.
Journal of Virology|October 6, 2006
Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of actionDirk Jochmans, Jérôme Deval, Bart Kesteleyn, et al.
Pageof 3